A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early -Stage Breast Cancer at High Risk of Recurrence (D-CARE)

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early -Stage Breast Cancer at High Risk of Recurrence (D-CARE)
StatusFinished
Effective start/end date27/09/10 → 24/09/18

Funding

  • Sandwell & West Birmingham Hospitals